Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kyle Thompson (NPI 1710111224)

Field	Value
Entity Type	Individual
Organization	Kyle Thompson
Address	2100 Providence Way
City	Idaho Falls
State	ID
ZIP	83404
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 12, 2009

Payer Source	Total Paid
Medicare	$4.5M
Medicaid	$0

Key Findings

This provider is operating squarely as a medical retina practice with a heavy emphasis on intravitreal biologic injections: J2777 (36.9K claims, $1.1M revenue, 23.7% of Medicare revenue), J0178 (1.4K claims, $960.4K revenue, 21.3%), and J2778 (4.7K claims, $828.8K revenue, 18.4%) together dominate the clinical mix and reflect routine administration of faricimab, aflibercept, and ranibizumab to Medicare beneficiaries. The presence of other injectable codes such as J2781 and J7312 further underscores a therapy-focused, infusion/injection–centric service line rather than a surgery-only or general ophthalmology practice model.

Revenue is highly concentrated in a small set of therapies: the top 3 Medicare codes by revenue account for 63.3% of this provider's total Medicare revenue, against a lifetime Medicare revenue base of $4.5M. That concentration indicates commercial sensitivity to shifts in drug utilization, reimbursement, or formulary preferences for these specific intravitreal agents.

This provider is effectively single-payer in scope for the data on file: Medicare shows $4.5M in lifetime revenue while Medicaid shows none (no Medicaid billing on file), so payer mix risk and volume planning should be treated as Medicare-centric. Absence of Medicaid activity means comparisons to in-state Medicaid peers are not applicable for operational benchmarking.

Competitive standing is mixed by drug: J2778 ranks #52 of 1208 providers nationally (96th percentile; notably above typical national volume) and J2781 ranks #16 of 490 providers nationally (97th percentile; notably above typical national volume), indicating well-above-typical national volume for these specific intravitreal therapies. By contrast, J2777 (rank #191 of 2039, 91th percentile; typical, unremarkable volume) and J0178 (rank #902 of 3204, 72th percentile; typical, unremarkable volume) are large revenue sources for this provider but described as more typical in national context, suggesting the provider is a regional high-volume prescriber for some newer or specialized agents while remaining a more average user of others.

Office-based care and imaging are a meaningful supporting component of the practice: 99214 appears with 1K claims and $94.8K revenue (2.1% of Medicare revenue) and ranks #10333 of 479517 providers (98th percentile; notably above typical national volume), while 92134 lists 1.9K claims and $52K revenue (1.2%) and ranks #1172 of 26868 providers (96th percentile; notably above typical national volume). These patterns indicate sustained follow-up visits and in-office retinal imaging capacity to support high-volume injection workflows.

The provider also maintains notable surgical/ procedural capability in retina: 67028 (2.5K claims, $241.9K revenue, 5.4% of Medicare revenue) ranks #166 of 4255 providers (96th percentile; notably above typical national volume) and 67036 (62 claims, $39.6K revenue, 0.9%) ranks #58 of 832 providers (96th percentile; notably above typical national volume). Presence of multiple high-percentile surgical codes suggests the practice performs both medical and operative retina services rather than strictly office-based injections.

Several drug and compound codes show high-revenue contributions but different statistical labels: J3490 (357 claims, $648K revenue, 14.4%) is listed as 94th percentile but labeled typical, unremarkable volume, while J7312 (658 claims, $104K revenue, 2.3%) and J2781 (2.8K claims, $334.8K revenue, 7.4%) are ranked in the 96–97th percentiles and labeled notably above typical national volume. This mix indicates that some high-dollar items are routine in national context, while others mark the provider as an above-typical adopter of certain intravitreal therapies or implants.

The provider is long-tenured on the Medicare NPI file, enumerated 2009-05-12 (~17 years ago), which supports interpretation of these billing patterns as the product of an established practice and referral base. For payers and competitors, that tenure combined with concentrated Medicare revenue and demonstrated procedural breadth suggests a stable, specialized retina practice whose financial exposure is tied closely to intravitreal drug utilization and Medicare reimbursement trends.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

26 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	36,900	$30	$1.1M
J0178	Injection, aflibercept, 1 mg	1,400	$690	$960.4K
J2778	Injection, ranibizumab, 0.1 mg	4,660	$180	$828.8K
J3490	Unclassified drugs	360	$1,820	$648K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	2,790	$120	$334.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,550	$100	$241.9K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	660	$160	$104K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,040	$90	$94.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,860	$30	$52K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	610	$80	$46.7K

Showing 1–10 of 26

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Kyle Thompson — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

26 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	3	20	670	$690	$541.7K
J2777	2	10	8,640	$30	$454.7K
J2778	1	10	1,190	$180	$352.5K
J3490	2	10	230	$880	$174.8K
J2781	1	10	990	$120	$153.8K
J7312	1	10	640	$160	$80.5K
67028	2	30	470	$90	$66.6K
67036	2	10	20	$1,040	$33.3K
67041	7	10	20	$1,170	$22.2K
67108	3	10	10	$1,130	$19.2K

Showing 1–10 of 26

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kyle Thompson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kentucky Medical Services Foundation, Inc	KY	Internal Medicine Physician	$0	$110.4M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Retina And Vitreous Associates Of Kentucky PLLC	KY	Retina Specialist (Ophthalmology) Physician	$0	$13.3M
Kentucky Medical Services Foundation	KY	Nurse Practitioner	$0	$12.5M
Nathan Steinle	CA	Retina Specialist (Ophthalmology) Physician	$9.5M	$0
Prema Abraham	SD	Retina Specialist (Ophthalmology) Physician	$7.1M	$0
Douglas Holmes	WY	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
John Kitchens	KY	Retina Specialist (Ophthalmology) Physician	$3.5M	$514.7K
Todd Purkiss	KY	Retina Specialist (Ophthalmology) Physician	$3.9M	$4.8K
Mitchell Goff	UT	Retina Specialist (Ophthalmology) Physician	$3.8M	$0

Nearby Providers

Other providers in the same ZIP code as Kyle Thompson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mountain View Hospital LLC	ID	General Acute Care Hospital	$0	$45.7M
Eastern Idaho Health Services Inc	ID	General Acute Care Hospital	$0	$12.1M
Rm Lab LLC	ID	Clinical Medical Laboratory	$1.1M	$8.2M
Medical Center For Children & Adolescents, PA	ID	Pediatrics Physician	$0	$8.8M
Aaa American Healthcare LLC	ID	Mental Health Counselor	$0	$8.7M
Intermountain Emergency Physicians	ID	Emergency Medicine Physician	$0	$6.6M
24-7 Professional Solutions	ID	In Home Supportive Care Agency	$0	$5.9M
Just 4 Kids Health LLC	ID	Urgent Care Clinic/Center	$0	$5.2M
Foothills Rehabilitation & Performance Services, PLLC	ID	Physical Therapist	$0	$5M
Innovative Health Care Concepts, Inc	ID	Developmental Disabilities Clinic/Center	$0	$4.8M

Kyle Thompson — Billing Profile & Reimbursement Data

Sign up for Kyle Thompson — Billing Profile & Reimbursement Data policy alerts

Kyle Thompson — Billing Profile & Reimbursement Data

Sign up for Kyle Thompson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References